N-Nitroso Nortriptyline D3 | N-Nitroso Amitriptyline EP Impurity C-D3
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. N-Nitroso Nortriptyline D3can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nitrosamines . N-Nitroso Nortriptyline D3 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline D3 CAS NO:NA is also known as N-Nitroso Amitriptyline EP Impurity C-D3 Chemically represented as N-(3-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propyl)-N-(methyl-d3)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline D3. We supply N-Nitroso Nortriptyline D3 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141906 |
| CAS No | NA |
| Mol.F. | C14H15N3O3 |
| Mol.Wt. | 273.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141907 |
| CAS No | NA |
| Mol.F. | C20H22N6O5 |
| Mol.Wt. | 426.4g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141908 |
| CAS No | NA |
| Mol.F. | C20H24N6O4 |
| Mol.Wt. | 412.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141909 |
| CAS No | NA |
| Mol.F. | C18H20N6O3 |
| Mol.Wt. | 368.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141910 |
| CAS No | NA |
| Mol.F. | C18H19N7O4 |
| Mol.Wt. | 397.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141911 |
| CAS No | NA |
| Mol.F. | C26H22FN3O2 |
| Mol.Wt. | 427.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141912 |
| CAS No | NA |
| Mol.F. | C33H33FN3O6 |
| Mol.Wt. | 586.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141913 |
| CAS No | NA |
| Mol.F. | C15H17N3O2 |
| Mol.Wt. | 271.3 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141914 |
| CAS No | NA |
| Mol.F. | C16H21ClN4O2 |
| Mol.Wt. | 336.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141915 |
| CAS No | NA |
| Mol.F. | C16H21ClN4O |
| Mol.Wt. | 320.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141916 |
| CAS No | NA |
| Mol.F. | C16H20ClN3O3 |
| Mol.Wt. | 337.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141917 |
| CAS No | NA |
| Mol.F. | C16H20ClN5O3 |
| Mol.Wt. | 365.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141918 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O3 |
| Mol.Wt. | 380.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141919 |
| CAS No | NA |
| Mol.F. | C16H21ClN4O |
| Mol.Wt. | 320.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141920 |
| CAS No | NA |
| Mol.F. | C14H16ClN3O2 |
| Mol.Wt. | 293.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141921 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O5S |
| Mol.Wt. | 444.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |